Αρχική World News Opinion: ‘Beating cancer means beating it for everyone’

Opinion: ‘Beating cancer means beating it for everyone’

Two women talking.

Cancer doesn’t exist in a vacuum. The factors that determine which groups in society face the greatest burden also have a role to play in who’s most likely to get cancer, and to die from it. These factors are complex, they are deeply woven into the fabric of our society – and they can’t be ignored.

We’ve long felt that Cancer Research UK has a role to play in tackling inequalities, and I have a long-held interest in Equality, Diversity and Inclusion. But the events of the past year brought issues of inequality into sharp focus, and that in turn focused our minds. In June we published our initial commitments, which included a commitment to becoming an organisation committed to EDI, and that we would develop a short-, medium- and long-term plan for how to get there.

I’m proud to be launching that strategy today. This marks a significant step forward for us as a charity, for our community and for our collective fight against cancer.

Michelle Mitchell, chief executive officer of Cancer Research UK.

Michelle Mitchell is Cancer Research UK’s chief executive.

Cancer Research UK is the largest funder of cancer research in the world. So we have a responsibility to make sure our research community is inclusive, diverse and thriving.

38 million people each year access health information developed by Cancer Research UK. So we must ensure that it is easy to access and easy to understand, for everyone.

We are a voice for people affected by cancer in the media, and to Governments. We have a responsibility to highlight where there are inequalities, and use our voice and our partnerships to make sure they’re tackled.

We’re a large organisation, employing 3,500 people and supported by 30,000 volunteers. Every person at Cancer Research UK needs to be supported to do their best work, we need to have a breadth of skills and experiences and the best leaders who also represent the communities we serve.

This strategy sets out the actions we’re taking to meet these responsibilities. We want to create a charity where everyone feels like they belong, benefits from, and participates in the work we do.

This means becoming an anti-racist charity, challenging racism and discrimination whenever we encounter it in the scope of our work.

I’m proud of the progress we’ve already made over the past few years. We’ve doubled female membership on research committees, addressed a lack of diversity in clinical trials and published a report on socioeconomic inequalities in cancer.

But we’ve also made mistakes. We could’ve done more to tackle racial biases in academic research, had a stronger voice on health inequalities, and acted quicker to make sure that our communications materials reflected the diversity of our community.

By publishing this plan, I want to make a public commitment to change for the better. We will share our progress each year, be transparent where we haven’t got it right, and always be open to learning. Because while this is a great step forward for Cancer Research UK, it is not the final step –we have to fulfil these commitments, learn as we go and in parallel, look towards our longer-term ambitions for change. As chief executive, I am personally committed to this and will be leading this change.

Michelle Mitchell is the chief executive of Cancer Research UK

Read more:

More on this topic

Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

EMA Recommends Granting a Marketing Authorisation for Sacituzumab Govitecan

On 14 October 2021, the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting...

Gym Offers Free Membership & Support To Those Struggling With Addiction

The Phoenix is a gym that people can go to if they’re struggling with addiction. The only cost of membership? 48 hours of sobriety. According...

Rookie Cop Saves Infant From Choking

Many of us may have an opportunity to become a hero before our life is over. For a police officer on the job, however,...

Hairstylist Creates Custom Wigs & Donates Them To Cancer Patients

Markeisha Wardell, owner of Rose Beauty Bar and Markeisha Rose Extensions, loves her job as a hairdresser, but understands that not everyone can afford...

Despite Proven Safety of HPV Vaccines, More Parents Have Concerns

October 22, 2021, by NCI Staff Credit: National Cancer Institute Despite more than 15 years of consistent evidence that HPV vaccines are safe and effective, a...

FDA Approves Atezolizumab as Adjuvant Treatment for Non-Small Cell Lung Cancer

On 15 October 2021, the US Food and Drug Administration (FDA) approved atezolizumab (Tecentriq, Genentech, Inc.) for adjuvant treatment following resection and platinum-based chemotherapy...